1. Home
  2. CURI vs STXS Comparison

CURI vs STXS Comparison

Compare CURI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$2.72

Market Cap

154.7M

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.43

Market Cap

164.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURI
STXS
Founded
N/A
1990
Country
United States
United States
Employees
42
N/A
Industry
Movies/Entertainment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.7M
164.1M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
CURI
STXS
Price
$2.72
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$5.83
$4.00
AVG Volume (30 Days)
280.7K
1.2M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
10.36%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$14.91
$28.22
Revenue Next Year
$12.91
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$1.24
52 Week High
$5.51
$3.59

Technical Indicators

Market Signals
Indicator
CURI
STXS
Relative Strength Index (RSI) 56.75 39.38
Support Level $2.32 N/A
Resistance Level $2.95 $1.97
Average True Range (ATR) 0.11 0.10
MACD 0.03 0.01
Stochastic Oscillator 98.57 30.77

Price Performance

Historical Comparison
CURI
STXS

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: